Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio | PRODUCT CODE: 1681253

Cover Image

PUBLISHER: TechNavio | PRODUCT CODE: 1681253

Global Obsessive-compulsive Disorder Drugs Market 2025-2029

PUBLISHED:
PAGES: 217 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

The obsessive-compulsive disorder drugs market is forecasted to grow by USD 395.3 million during 2024-2029, accelerating at a CAGR of 6.3% during the forecast period. The report on the obsessive-compulsive disorder drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of OCD, launch of new molecules, and increasing awareness programs for OCD.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20255.5%
CAGR6.3%
Incremental Value$395.3 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's obsessive-compulsive disorder drugs market is segmented as below:

By Product

    • SSRI
    • TCA
    • Others

By Route Of Administration

    • Oral
    • Parentral

By Therapy

    • Cognitive behavioral therapy
    • Augmentation therapy
    • Aversion therapy
    • Systematic desensitization
    • Others

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the increased use of off-label therapies as one of the prime reasons driving the obsessive-compulsive disorder drugs market growth during the next few years. Also, expanding research on first-in-class peptide therapeutics and increasing generic approvals will lead to sizable demand in the market.

The report on the obsessive-compulsive disorder drugs market covers the following areas:

    • Obsessive-Compulsive Disorder Drugs Market sizing
    • Obsessive-Compulsive Disorder Drugs Market forecast
    • Obsessive-Compulsive Disorder Drugs Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading obsessive-compulsive disorder drugs market vendors that include Alembic Ltd., Anant Pharmaceuticals Pvt. Ltd., Apotex Inc., BrainsWay Ltd., Dellwich Healthcare LLP, Eli Lilly and Co., Eridanus Healthcare, Flamingo Pharmaceuticals Ltd., GlaxoSmithKline PLC, H Lundbeck AS, Jabs Biotech Pvt. Ltd., Jazz Pharmaceuticals PLC, Kabir Life Sciences, Lepu Medical Technology Beijing Co. Ltd., Lifecare Neuro Products Ltd., Novartis AG, Pfizer Inc., and Wellona Pharma. Also, the obsessive-compulsive disorder drugs market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73649

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product
    • Executive Summary - Chart on Market Segmentation by Route of Administration
    • Executive Summary - Chart on Market Segmentation by Therapy
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Obsessive-Compulsive Disorder Drugs Market 2019 - 2023
    • Historic Market Size - Data Table on Global Obsessive-Compulsive Disorder Drugs Market 2019 - 2023 ($ million)
  • 5.2 Product segment analysis 2019 - 2023
    • Historic Market Size - Product Segment 2019 - 2023 ($ million)
  • 5.3 Route of Administration segment analysis 2019 - 2023
    • Historic Market Size - Route of Administration Segment 2019 - 2023 ($ million)
  • 5.4 Therapy segment analysis 2019 - 2023
    • Historic Market Size - Therapy Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI in Global Obsessive-Compulsive Disorder Drugs Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

  • 8.1 Market segments
    • Chart on Product - Market share 2024-2029 (%)
    • Data Table on Product - Market share 2024-2029 (%)
  • 8.2 Comparison by Product
    • Chart on Comparison by Product
    • Data Table on Comparison by Product
  • 8.3 SSRI - Market size and forecast 2024-2029
    • Chart on SSRI - Market size and forecast 2024-2029 ($ million)
    • Data Table on SSRI - Market size and forecast 2024-2029 ($ million)
    • Chart on SSRI - Year-over-year growth 2024-2029 (%)
    • Data Table on SSRI - Year-over-year growth 2024-2029 (%)
  • 8.4 TCA - Market size and forecast 2024-2029
    • Chart on TCA - Market size and forecast 2024-2029 ($ million)
    • Data Table on TCA - Market size and forecast 2024-2029 ($ million)
    • Chart on TCA - Year-over-year growth 2024-2029 (%)
    • Data Table on TCA - Year-over-year growth 2024-2029 (%)
  • 8.5 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 8.6 Market opportunity by Product
    • Market opportunity by Product ($ million)
    • Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Route of Administration

  • 9.1 Market segments
    • Chart on Route of Administration - Market share 2024-2029 (%)
    • Data Table on Route of Administration - Market share 2024-2029 (%)
  • 9.2 Comparison by Route of Administration
    • Chart on Comparison by Route of Administration
    • Data Table on Comparison by Route of Administration
  • 9.3 Oral - Market size and forecast 2024-2029
    • Chart on Oral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oral - Market size and forecast 2024-2029 ($ million)
    • Chart on Oral - Year-over-year growth 2024-2029 (%)
    • Data Table on Oral - Year-over-year growth 2024-2029 (%)
  • 9.4 Parentral - Market size and forecast 2024-2029
    • Chart on Parentral - Market size and forecast 2024-2029 ($ million)
    • Data Table on Parentral - Market size and forecast 2024-2029 ($ million)
    • Chart on Parentral - Year-over-year growth 2024-2029 (%)
    • Data Table on Parentral - Year-over-year growth 2024-2029 (%)
  • 9.5 Market opportunity by Route of Administration
    • Market opportunity by Route of Administration ($ million)
    • Data Table on Market opportunity by Route of Administration ($ million)

10 Market Segmentation by Therapy

  • 10.1 Market segments
    • Chart on Therapy - Market share 2024-2029 (%)
    • Data Table on Therapy - Market share 2024-2029 (%)
  • 10.2 Comparison by Therapy
    • Chart on Comparison by Therapy
    • Data Table on Comparison by Therapy
  • 10.3 Cognitive behavioral therapy - Market size and forecast 2024-2029
    • Chart on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cognitive behavioral therapy - Market size and forecast 2024-2029 ($ million)
    • Chart on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
    • Data Table on Cognitive behavioral therapy - Year-over-year growth 2024-2029 (%)
  • 10.4 Augmentation therapy - Market size and forecast 2024-2029
    • Chart on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Augmentation therapy - Market size and forecast 2024-2029 ($ million)
    • Chart on Augmentation therapy - Year-over-year growth 2024-2029 (%)
    • Data Table on Augmentation therapy - Year-over-year growth 2024-2029 (%)
  • 10.5 Aversion therapy - Market size and forecast 2024-2029
    • Chart on Aversion therapy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Aversion therapy - Market size and forecast 2024-2029 ($ million)
    • Chart on Aversion therapy - Year-over-year growth 2024-2029 (%)
    • Data Table on Aversion therapy - Year-over-year growth 2024-2029 (%)
  • 10.6 Systematic desensitization - Market size and forecast 2024-2029
    • Chart on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
    • Data Table on Systematic desensitization - Market size and forecast 2024-2029 ($ million)
    • Chart on Systematic desensitization - Year-over-year growth 2024-2029 (%)
    • Data Table on Systematic desensitization - Year-over-year growth 2024-2029 (%)
  • 10.7 Others - Market size and forecast 2024-2029
    • Chart on Others - Market size and forecast 2024-2029 ($ million)
    • Data Table on Others - Market size and forecast 2024-2029 ($ million)
    • Chart on Others - Year-over-year growth 2024-2029 (%)
    • Data Table on Others - Year-over-year growth 2024-2029 (%)
  • 10.8 Market opportunity by Therapy
    • Market opportunity by Therapy ($ million)
    • Data Table on Market opportunity by Therapy ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.9 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.10 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.11 Mexico - Market size and forecast 2024-2029
    • Chart on Mexico - Market size and forecast 2024-2029 ($ million)
    • Data Table on Mexico - Market size and forecast 2024-2029 ($ million)
    • Chart on Mexico - Year-over-year growth 2024-2029 (%)
    • Data Table on Mexico - Year-over-year growth 2024-2029 (%)
  • 12.12 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.13 Italy - Market size and forecast 2024-2029
    • Chart on Italy - Market size and forecast 2024-2029 ($ million)
    • Data Table on Italy - Market size and forecast 2024-2029 ($ million)
    • Chart on Italy - Year-over-year growth 2024-2029 (%)
    • Data Table on Italy - Year-over-year growth 2024-2029 (%)
  • 12.14 The Netherlands - Market size and forecast 2024-2029
    • Chart on The Netherlands - Market size and forecast 2024-2029 ($ million)
    • Data Table on The Netherlands - Market size and forecast 2024-2029 ($ million)
    • Chart on The Netherlands - Year-over-year growth 2024-2029 (%)
    • Data Table on The Netherlands - Year-over-year growth 2024-2029 (%)
  • 12.15 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.16 Spain - Market size and forecast 2024-2029
    • Chart on Spain - Market size and forecast 2024-2029 ($ million)
    • Data Table on Spain - Market size and forecast 2024-2029 ($ million)
    • Chart on Spain - Year-over-year growth 2024-2029 (%)
    • Data Table on Spain - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Alembic Ltd.
    • Alembic Ltd. - Overview
    • Alembic Ltd. - Product / Service
    • Alembic Ltd. - Key offerings
    • SWOT
  • 15.5 Anant Pharmaceuticals Pvt. Ltd.
    • Anant Pharmaceuticals Pvt. Ltd. - Overview
    • Anant Pharmaceuticals Pvt. Ltd. - Product / Service
    • Anant Pharmaceuticals Pvt. Ltd. - Key offerings
    • SWOT
  • 15.6 Apotex Inc.
    • Apotex Inc. - Overview
    • Apotex Inc. - Product / Service
    • Apotex Inc. - Key news
    • Apotex Inc. - Key offerings
    • SWOT
  • 15.7 BrainsWay Ltd.
    • BrainsWay Ltd. - Overview
    • BrainsWay Ltd. - Product / Service
    • BrainsWay Ltd. - Key offerings
    • SWOT
  • 15.8 Eli Lilly and Co.
    • Eli Lilly and Co. - Overview
    • Eli Lilly and Co. - Product / Service
    • Eli Lilly and Co. - Key offerings
    • SWOT
  • 15.9 Eridanus Healthcare
    • Eridanus Healthcare - Overview
    • Eridanus Healthcare - Product / Service
    • Eridanus Healthcare - Key offerings
    • SWOT
  • 15.10 Flamingo Pharmaceuticals Ltd.
    • Flamingo Pharmaceuticals Ltd. - Overview
    • Flamingo Pharmaceuticals Ltd. - Product / Service
    • Flamingo Pharmaceuticals Ltd. - Key offerings
    • SWOT
  • 15.11 GlaxoSmithKline Plc
    • GlaxoSmithKline Plc - Overview
    • GlaxoSmithKline Plc - Business segments
    • GlaxoSmithKline Plc - Key news
    • GlaxoSmithKline Plc - Key offerings
    • GlaxoSmithKline Plc - Segment focus
    • SWOT
  • 15.12 H Lundbeck AS
    • H Lundbeck AS - Overview
    • H Lundbeck AS - Product / Service
    • H Lundbeck AS - Key offerings
    • SWOT
  • 15.13 Jazz Pharmaceuticals Plc
    • Jazz Pharmaceuticals Plc - Overview
    • Jazz Pharmaceuticals Plc - Product / Service
    • Jazz Pharmaceuticals Plc - Key news
    • Jazz Pharmaceuticals Plc - Key offerings
    • SWOT
  • 15.14 Lepu Medical Technology Beijing Co. Ltd.
    • Lepu Medical Technology Beijing Co. Ltd. - Overview
    • Lepu Medical Technology Beijing Co. Ltd. - Product / Service
    • Lepu Medical Technology Beijing Co. Ltd. - Key offerings
    • SWOT
  • 15.15 Lifecare Neuro Products Ltd.
    • Lifecare Neuro Products Ltd. - Overview
    • Lifecare Neuro Products Ltd. - Product / Service
    • Lifecare Neuro Products Ltd. - Key offerings
    • SWOT
  • 15.16 Novartis AG
    • Novartis AG - Overview
    • Novartis AG - Business segments
    • Novartis AG - Key news
    • Novartis AG - Key offerings
    • Novartis AG - Segment focus
    • SWOT
  • 15.17 Pfizer Inc.
    • Pfizer Inc. - Overview
    • Pfizer Inc. - Product / Service
    • Pfizer Inc. - Key news
    • Pfizer Inc. - Key offerings
    • SWOT
  • 15.18 Wellona Pharma
    • Wellona Pharma - Overview
    • Wellona Pharma - Product / Service
    • Wellona Pharma - Key offerings
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!